Artículos Científicos en Ingles

CERTAIN ENVIRONMENTAL POLLUTANTS MAY CONTRIBUTE TO POOR KIDNEY HEALTH In an analysis of all relevant studies, exposure to...	AMERICAN SOCIETY OF NEPHROLOGY PARTNERS WITH RENAL FELLOW NETWORK BLOG On the 10th anniversary of the Renal Fellow Network (RFN...	Low eGFR, Worsening Renal Function Predict Higher Post-PCI Death Risk Low eGFR and worsening renal function are independently...
Gout Attack Risk Lowered With Interleukin-1ß Blockade Inhibition of IL-1ß with canakinumab significantly...	Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis Over a 5-year period, the drug was well tolerated and...	Study overturns what we know about kidney stones New research uses cutting-edge technology to study...
Why some people are at risk of gout Researchers have helped characterize a genetic variant...	Higher Caffeine Intake May Decrease Death Risk in CKD Among individuals with chronic kidney disease, those in...	CKD Patients Use Proton Pump Inhibitors Longer Researchers find that physicians prescribe much longer...
Anemia Severity Linked to LVH Risk in Pediatric Dialysis Time-averaged hemoglobin levels, not hemoglobin cycling...

MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney Injury Acute kidney injury (AKI) is a common complication of...	Single-Cell RNA Sequencing of the Adult Mouse Kidney: From Molecular Cataloging of Cell Types to Disease-Associated Predictions Single-cell transcriptomic analyses have emerged as a...	Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling Mutations in the NPHS2 gene, which encodes the podocyte...
In Reply to ‘Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy’ We agree with Duineveld et al1 that no definitive...	Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy Based on a retrospective evaluation of patients with C3 ...

Menú de usuario